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1. Introduction 
It is well known that postmenopausal osteoporosis is related to severe decreases in the 
serum estrogen levels. Estrogen deficiency produces an imbalance in the bone remodeling 
balance which is associated with a reduced bone volume and higher fracture risk. Androgen 
deficiency also produces osteoporosis by directly affecting bone cells. In addition, androgen 
was demonstrated to be present during the fetal period, and it is considered to play an 
essential role in the sexual differentiation of males. Therefore, both sex hormones, androgen 
and estrogen, are great important for bone homeostasis not only in females but also in 
males. This is further supported by the fact that both males and females express androgen 
receptor (AR), estrogen receptor-alpha (ER) and estrogen receptor-beta (ER). Androgen 
and estrogen react with the AR and ER and ERrespectively. It is thus speculated that 
they mutually regulate themselves during bone development and remodeling. 
Up to present, various studies have examined the roles of estrogen and its receptors to 
explore potential methods for preventing or treating postmenopausal osteoporosis (Judd et 
al., 1983; Kousteni et al., 2002; Martin-Milan et al., 2010; Pietschmann et al., 2008). Recent 
clinical studies have reported that the prevention of hip bone fractures and vertebral 
deformities is highly pertinent to improving the quality of life for older people (Chang et al., 
2004; O’Neill et al., 2009). To avoid these incidents, we have to try to achieve adequate peak 
bone mass during adolescent growth, it is also important to understand the bone growth, 
because this is currently an under-investigated area. In adult animal experiments, 
orchiectomy and ovariectomy reduced both the bone volume and density. Furthermore, the 
bone volume loss was induced not only in the long bones but also in the mandibular 
condyles (Fujita et al., 2001). In addition, we have reported that these phenomena were also 
shown in immature mice (Fujita et al., 2006). Therefore, the influence of sex hormones on 
bone remodeling has been demonstrated in the craniofacial region. In orthodontic and 
orthopedic treatment, it is especially, difficult to predict bone growth including craniofacial 
and mandibular growth during adolescence. The full nature of bone growth, in association 
with sex hormones remains to be fully elucidated.  
The ratio of osteoporosis patient in Japan based on the diagnosed by Japanese society for 
bone and mineral research is reported 24% of over fifty-year-old people and it is indicated 
the number of patients is higher than those in USA and European countries (Orimo, 2000). 
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Therefore, we all recognize osteoporosis is one of serious social problems in Japan. This fact 
indicates that the influences of sex hormones on bone metabolism are very complicated, and 
the mechanism is very difficult to be understood.  
Peak bone mass, in general, is acquired from childhood to adolescence, but 35% of cortical 
bone and 50% of trabecular bone are lost gradually thereafter after. The importance of 
preventive medicine thus has been gradually recognized in the field of orthopaedic surgery 
with a concept that peak bone mass is to be increased and saved during childhood as much 
as possible (Lapauw et al., 2009; Kaufman, 2009). Such an idea has been attracting a special 
attention in the field of clinical medicine for the prevention of osteoporosis. The importance 
of normal development and growth of bone until adolescence has also been reported 
(Karlsson et al., 2008; Wang et al., 2008). This fact suggested that if we are able to increase 
the peak bone mass during adolescence as possible by providing some effective nutrition for 
increasing bone volume, it may leads to prevent the risk and to delay the appearance of 
osteoporosis. 
According to the prevention and treatment of guideline in osteoporosis, it was 
recommended to intake daily dose of calcium is higher (Rosen  Gallagher, 2011). However, 
the amount of calcium intake is approximately 500mg per one day in practically, and even 
added the consumption applied by supplement, could not reach daily objective intake. 
A newly developed snack used in our experiments contains appropriate amounts of 
minerals (calcium and magnesium ) and casein phosphopeptide (CPP) as well as soybean 
isoflavone which has a sex hormone-like action, which is recognized as a specified food for 
health, is also included. The objective of this chapter was to introduce the effects of bone 
remodeling including bone volume, density and strength in osteoporosis and healthy 
growing mice fed a special composition nutrition.   
2. Nutrition 
2.1 Function of nutrition 
Recently, it was focused on the prevention of osteoporosis and life style related disease like 
a diabetic and heart disease. Under such situation, people are well considered the food 
function. It is well known that the function of foodstuff has mainly for nutrition and taste. 
Additionally, it has also the important function as a decreasing of risk in some disease. The 
development of foodstuff which has the specific function for living body adjustment is 
going forward actively in nowadays, therefore the daily food which we intake were 
diversify. Now it was reported that there are detected and demonstrated in some nutrition 
that the function of anti-thrombosis, anti-oxidation, encouragement to assimilate calcium, 
controlling of blood pressure and improvement of cholesterol readings as a food for special 
health uses and Japanese government had approved it (Yamada et al., 2008). For example, 
beta-carotene was known as a great nutrition because of its essential function, foodstuff 
factor as a provitamin, taste factor by its color in vegetable and fruit, and the role of anti-
oxidation (Kim et al., 2010).  
2.2 Casein phosphopeptide 
CPP is also well known as a factor of encouragement to assimilate calcium. Milk and dairy 
products contains CPP together with functional protein like a milky basic protein and 
lactoferrin. Casein as a milk protein is a protein containing phosphoric acid, and is 
decomposed into oligopeptide of various sizes by the digestive enzyme. It became 
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clarified that special protein containing many phosphoric acid called CPP. Generally, 
calcium is the fifth abundant element by mass in the human body, where it is a common 
cellular ionic messenger with many functions, and serves also as a structural element in 
bone. And it has four stable isotopes (40Ca, 42Ca, 43Ca and 44Ca) plus two more isotopes 
(46Ca and 48Ca). 97% of naturally occurring calcium is in the form of 40Ca which is a one of 
daughter products of 40K decay, along with 40Ar (Mueller  Boehm, 2011; Skulan  
DePaolo, 1999). Calcium is hard to be absorbed in human body since it combines with 
negative ion such as a phosphoric acid in a small intestine. However, CPP prevents own 
insoluble and promote its efficiency of absorption in a small intestine due to a part of 
serine residue is phosphorylated and the ionic bond of CPP is carried out to calcium with 
the negative ion of phosphate group. 
Moreover, the function in the promotion of absorption efficacy of CPP, it is positively 
applied in the form of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), 
and is widely well-known as Recaldent. CPP from the major protein of milk have the 
remarkable ability to stabilize calcium, phosphate and fluoride ions as water soluble 
amorphous complexes that provide bioavairable calcium, phosphate and fluoride ions to 
the tooth. Animal and short-term human clinical trials to repair early staged of tooth 
decay by replacing the calcium and phosphate ions lost due to decay (Reynolds, 2009; 
Llena et al., 2009). Long-term controlled clinical trials also have demonstrated the efficacy 
of CPP-ACP is slowing the progression of dental caries and in regressing early stages of 
tooth decay (Andersson et al., 2007; Morgan et al., 2008). Moreover, it was reported that it 
is effective rather than the 500ppm sodium fluoride paste which the dentists have used 
conventionally for the purpose of prevention of tooth decay (Zhang et al., 2011; 
Altenburger et al., 2010). 
On the other hand, it was reported that the calcium in food exists 50~60% in milk, 
approximately 20% in small fish and approximately 30% in vegetable. But, absorption 
efficacy of calcium in human body is not much excellent. Therefore, CPP is further 
developed as “food suitable for the people of calcium shortage” such as suger-free gum, 
tooth cream, dairy milk and another drink and Japanese tofu. However, with such 
professional tool, food and drink form, we speculated that it will be probably difficult to 
take freely and daily for the purpose of increasing the absorption efficacy of calcium.  
3. Animal study 
3.1 Materials and methods 
Fifty male and fifty female C57BL/6J mice of twelve-week-old and thirty male and thirty 
female C57BL/6J mice of five-day-old (Jackson Laboratory, Bar Harbar, ME, USA) were 
used in this experiment and divided respectively into eight groups with ten in each sex. In 
the experimental groups, orchiectomy (ORX) and ovariectomy (OVX) were performed for 
ten mice of twelve-week-old in each gender at the beginning of experiment to create the 
situation of osteoporosis model. ORX and OVX were performed by means of a stereoscopic 
microscope (SZX9, Olympus Optical Co., Tokyo, Japan) under general anesthesia with 
sodium pentobarbital, whereas the control mice underwent sham operation. The detail of 
time schedules in adult and growing mice during a series of experiment are shown in Table 
1 and 2, respectively. These animals were treated under the ethical regulations defined by 
the Ethics Committee, Hiroshima University Faculty of Dentistry. 
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Table 1. Time schedule during experiments in adult mice 
 
 
Table 2. Time schedule during experiments in growing mice 
We prepared three types of powder diet e.g.: normal calcium diet (NCD, Ca : 0.9%, Clea 
Japan Co., Tokyo, Japan), low calcium diet (LCD, Ca : 0.63%, Clea Japan Co.,) and special 
diet (SCD, Ca : 0.9%) developed as a new bean snack. NCD with 0.9% calcium was made on 
basis of objective consumption of calcium intake in humans defined by the Ministry of 
Health, Labour and Welfare (MHLW) in Japan. LCD including 0.63% calcium was made on 
the basis of actual calcium consumption in Japanese. The SCD containing LCD and the 
newly developmental snack, was supplied as a diet including calcium content same as NCD. 
The newly developmental snack was composed of calcium, magnesium, CPP and black 
soybean. As the mainly composition, 1.3% of calcium, 0.6% of magnesium, 0.15% of CPP 
and 12.8% of black soybean were included in this snack. NCD was given up to six weeks 
after sham operation in the group 1 and 6. Other six groups were given LCD until six weeks 
after gonadectomy. Six weeks after surgery, group 3, 5 and 8 in each sex were given SCD 
including the newly developed bean snack. 
Eighteen weeks after surgery, all the animals were sacrified under general anesthesia and 
the femur was fixed with 4% formaldehyde and prepared for histomorphometric analysis. 
Peripheral Quantitive Computed Tomography (XCT Research SA, Stratec Medizintechnik 
GmbH, Pforzheim, Germany) was used to quantify bone density and bone mineral content. 
Femur was measured at a point 1.4mm distal area from chondrocyte growth plate. The 
cortical bone area was defined as over 690mg/cm3 threshold and the trabecular bone area 
was defined as under 395mg/cm3 threshold. Moreover, bone strength of femur performed 
by under three point flexural test was also executed in growing mice. 
We performed pairwise comparisons (Fisher) to examine the difference in measured values 
between the groups with a confidence level greater than 95%. All the data are presented as 
means±standard deviations. 
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3.2 In ORX and OVX mice 
Figure 1 shows the photographs of femur section examined by pQCT at the end of 
experiment. Irrespective of the sex differences, the trabecular bone volume surrounded by 
the thick cortical bone was maintained at high level in the control groups, in sham operated 
mice fed NCD in particular (group 1). Meanwhile, trabecular bone volume was decreased 
moderately in the experimental group 2 with LCD as compared with control mice. 
Furthermore, the group 4, gonadectomized mice fed LCD exhibited an excessive decrease in 
bone volume as compared with the groups 1 and 2. On the other hand, the femur section in 
the group 5, osteoporosis model mice given SCD, presented a prominent recovery of 
trabecular bone volume. 
 
 
 
Fig. 1. Photographs of femoral section in adult mice. 
As a result of pQCT analysis, similar phenomena were observed as mentioned above for the 
femur structures. The trabecular bone density of gonadectomized mice fed SCD was 
significantly increased as compared with sham opereated mice given LCD in both genders 
(Fig. 2). Moreover, the bone density was also significantly increased only in the female mice 
of group 5 as compared with sham operated mice fed NCD. 
For the cortical bone density, different findings from above mentioned results were 
obtained. Improvement effect was especially revealed in the gonadectomized mice given 
SCD (group 5) (Fig. 3). Additionally, it was also shown in the sham operated mice fed SCD 
(group 3) compared with the sham operated mice fed LCD (group 2). These tendencies were 
observed in both sexes. 
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Fig. 2. Trabecular bone density in adult mice 
 
 
 
 
 
Fig. 3. Cortical bone density in adult mice 
Subsequently, the total bone density was apparently increased as compared with other 
sham operated mice. The reason may be due to SCD supplied to the gonadectomized mice, 
especially in the female mice (Fig. 4). 
For bone mineral content, the groups 3 and 5 mice given SCD exhibited a significant 
increase as compared with the groups 1 and 2, especially in female mice. It is demonstrated 
from these findings that the newly development snack is very effective for the improvement 
of reduced bone quality and controlling of osteoporosis (Fig. 5). 
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Fig. 4. Total bone density in adult mice 
 
 
 
 
 
 
Fig. 5. Bone mineral density in adult mice 
3.3 In young mice 
The results of trabecular bone density were shown in Figure 6. The mice fed NCD revealed 
around 40 to 50 mg/cm3 in density, but by the cause of changing food to LCD, it lead to 
decrease in both sexes. Under such situation, in case of group 8, mice fed SCD from after six 
weeks to the end of experiment, trabecular bone density showed significantly increased 
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compared with mice fed LCD, therefore, there is no significant differences between control 
mice of group 6 and mice fed food which is changing to SCD after feeding LCD of group 8. 
In the results of cortical bone density, similar phenomena were observed with trabecular bone 
density, the cortical bone density of mice fed LCD revealed significantly decreased compared 
with mice given NCD (Fig. 7). However, by the feed changing to SCD, cortical bone density 
wasn’t getting better as contrasted with the results of trabecular bone density and the results of 
cortical bone density in adult mice. These tendencies were observed in both sexes. As a result, 
only in female mice, total bone density also showed the sufficient effect of improvement (Fig. 
8). There is no significant difference between group 6 and 8 in male mice. 
 
 
 
 
 
Fig. 6. Trabecular bone density in growing mice 
 
 
 
 
 
Fig. 7. Cortical bone density in growing mice 
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Fig. 8. Total bone density in growing mice 
In the results of bone mineral content, Male mice after fed SCD showed no significant 
differences as compared with the control mice (Fig. 9). On the other hand, female mice of 
group 7 and 8 showed significantly reduced bone mineral content as compared with mice of 
group 6.  
According to the results of total bone density and bone mineral content, the results of three 
point flexural test also showed same tendency in male mice (Fig. 10). Meanwhile, although 
the results of group 8 showed significant lower than the one of group 6 in total bone density 
and bone mineral content, group 7 and 8 demonstrated same level of group 6. 
 
 
 
 
Fig. 9. Bone mineral content in growing mice 
www.intechopen.com
 
Osteoporosis 
 
774 
 
 
Fig. 10. Three point flexural test in growing mice 
4. Discussion 
Osteoporosis is generally thought of as a disease that affects females, because the prevalence 
of osteoporosis and the rate of fracture are much higher in postomenomausal females than 
in older males. However, the absolute number of male patients affected by osteoporosis and 
fractures has been reported to be large. Older Asian males with low serum estradiol levels also 
display elevated bone loss and increased risk of fractures similar to the findings in Caucasians 
(Woo et al., 2011; Moayyeri et al., 2009). The main concern of treatment in osteoporosis 
research is to prevent bone volume loss by decreasing the progression of bone resorption. 
Nevertheless, the current knowledge is not sufficient to identify the precise causes of 
osteoporosis and all of the subjects at risk. As a result, recent studies have indicated that 
weight-bearing activity and possibly calcium supplements are beneficial if they are begun 
during childhood, preferably before puberty. The achievement of optimal peak bone mass is 
important to prevent the risk of bone fracture due to osteoporosis in the future. 
The sex hormones are known to be important for the regulation of reproductive functions. 
They induce sexual differentiation before birth, and sexual maturation during puberty in 
both genders. They also exert influences on the nervous and cardiovascular systems and are 
important in the development of the skeletal structure. There are two types of sex hormones, 
androgens and estrogens. These hormones are secreted mainly from the testis and ovaries. 
Testosterone can activate the androgen receptor either directly or indirectly after conversion 
to DHT by 5-reductase. Moreover, it is well known that testosterone is also converted into 
17-estradiol by P450 aromatase, which activates the estrogen receptors (alpha and beta). 
Based on this facts, Ovariectmized and Orchiectomized animals provide an excellent model 
to study osteoporosis due to estrogen and androgen deficiency in both genders. Both OVX 
and ORX mice exhibit marked bone loss with increased bone resorption. It was also 
reported that a loss in bone mineral density in ORX mice was evident between 1 to 4 months 
post-surgery, and histomorphometric evaluations revealed that this occurred more rapidly 
and with greater sensitivity in a rat model. 
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This snack we had developed was composed of calcium, magnesium, CPP and black 
soybean. We have examined into body weight and height of all mice during experimental 
period. However, all mice of supplied food in these measurements were no significant 
difference compared with the control groups in both sexes (data were not shown). In 
addition, the amount of all nutrition including supplied food was restrained according the 
instructions of MHLW in Japan. Therefore, we assumed that supplied special diet food has 
no occurrence of side effect following snack administration.  
It is well known that calcium intake decreases the risk of bone fracture. It was also reported 
that the calcium supplementation suppress bone formation when magnesium is deficient 
(Mora  Gilsanz, 2003). Based on these reports, we designed to mix calcium and magnesium 
at an appropriate proportion of 2 to 1. These contents in this snack were compounded to 
fulfill ninety percentage of the daily-required nutrition defined by MHLW in Japan. 
It was also reported that addition of CPP will have a beneficial effect on the absorption of 
calcium (Dontas  Yiannakopoulos, 2007). In Japan, CPP was accredited as a food for 
qualified health uses by MHLW. Accordingly, we add a certain amount of CPP to absorb 
mineral content easily. 
The black soybean contains isoflavone which is widely accepted to have a weak estrogen 
activity, and to be able to bind estrogen receptor. Actually, Brandi and Miyauchi et al., 
reported that isoflavone had either effect for the suppression of bone resorption or 
enhancement of bone formation, affecting directly both osteoclasts and osteoblasts (Brandi, 
2003; Miyauchi et al., 1996). In addition, isoflavone was revealed to affect bone metabolism 
similarly to the sex hormone-like effect in male (Chavarro et al., 2008). Recently, it was also 
reported that isoflavones have revealed inhibition of bone loss in castrated male mice and 
growing male mice respectively (Fujioka et al., 2007; Ishimi et al., 2002; Khalil et al., 2005). 
Under such background, a new snack was developed by use of black soybean. The amount 
of isoflavone in this snack was determined with a special reference to the amount of safety 
surplus nutrition per day defined by MHLW. 
Decrease in the trabecular and cortical bone volumes after gonadectomy has already been 
demonstrated by our previously reports (Fujita et al., 2001, 2004). We also reported that 
bone growth was significantly suppressed in the gonadectomized mice immediately after 
birth (Fujita et al., 2006). Moreover, we clarified that decrease in bone volume was occurred 
four weeks after gonadectomy. According to these results, we examined bone density of the 
femur six weeks after ovariectomy and orchiectomy. 
The density of trabecular and cortical bones in the gonadectomized mice given LCD was 
significantly lower than in the sham operated mice given NCD and LCD, respectively. It 
was revealed that the deficiency of calcium intake caused decrease in bone density, under 
sex hormone disturbances in particular. Therefore, it is speculated that the bone density is 
below the optimal level in Japanese and fracture risk may become higher for aged people. 
These findings also support that the incidence of primary osteoporosis is higher in Japan 
than in American and European countries.  
The bone metabolism is classified into two types, high turnover type to accelerate both bone 
formation and resorption and low turnover type caused by degradation of bone formation. 
In this study, twelve-week-old mice with sham operation fed LCD are regarded as young 
growing humans with low turnover type, whereas gonadectomy mice to simulate sex 
hormone disturbance in the experimental groups are assumed to be under the condition of 
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postmenopausal osteoporosis as a high turnover type. Irrespective of the turnover types, 
however, the bone density in the group 5 given appropriate amount of calcium by 
supplying SCD exhibited a remarkable increase. It is thus suggested that sufficient calcium 
quantity through nutrition of newly developed bean snack enhanced bone formation 
irrespective of age.  
It is reported that postmenopausal women with daily calcium intake of less than 400mg 
experience significant bone loss and that calcium intake of 800mg per day is effective for 
improving postmenopausal bone loss (Dawson-Hughes et al., 1990; Reid et al., 1993). On the 
other hand, it is well known that improvement effect against bone volume loss by calcium 
intake is available only at the initial stage of treatment. In addition, Riggs et al., clarified that 
the effect on bone loss is weaker than those reported for estrogen and bisphosphonates 
therapy, indicating that calcium supplements alone can’t substitute treatment for 
osteoporosis (Riggs et al., 1998). In this study, longitudinal effect of newly developmental 
snack intake was not examined. However, It is hopefully anticipated that new bean snack 
could contributed to the enrichment of QOL as a nutrition function food, because of it was 
contain of several ingredients to promote assimilation efficiency of calcium. 
5. Conclusions 
The new snack we developed included proper amount of calcium, magnesium, CPP and 
black soybean. When this product was given to the osteoporosis model mice, bone density 
of the femur was significantly increased. From these results, it is suggested that this product 
supplement promote bone formation irrespective of gender and age. We demonstrated that 
newly developmental snack supplements may be a useful preventive measure for the 
people whose bone mineral density values are less than the ideal condition. 
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